Shin Ae Kim

Title: The Innovations of Shin Ae Kim

Introduction

Shin Ae Kim is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target autotaxin activity. His work is crucial for addressing various diseases that are influenced by this enzyme.

Latest Patents

Shin Ae Kim holds a patent for a piperidine derivative and a pharmaceutical composition for inhibiting autotaxin. This patent describes a piperidine derivative compound, along with its hydrates, solvates, and pharmaceutically acceptable salts. The pharmaceutical composition is designed for the prevention or treatment of diseases related to autotaxin activity. The compound exhibits excellent inhibitory activity against autotaxin, making it a promising candidate for treating fibrotic diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, metabolic diseases, cancer and cancer metastasis, ocular diseases, cholestatic forms, chronic pruritus, and organ transplant rejection.

Career Highlights

Shin Ae Kim is currently associated with Nextgen Bioscience Co., Ltd., where he continues to innovate in the pharmaceutical sector. His expertise in developing effective treatments has positioned him as a valuable asset in the industry.

Collaborations

Some of his notable coworkers include Bong Yong Lee and Young Ah Shin. Their collaborative efforts contribute to the advancement of research and development in their field.

Conclusion

Shin Ae Kim's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in the area of autotaxin inhibition, hold promise for the treatment of various serious health conditions.